Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

New Product Briefs: Abbott Glucose Monitor, Boston Sci EP Mapping System Gain 510(k)s

This article was originally published in The Gray Sheet

Executive Summary

Abbott’s FreeStyle Precision Pro blood glucose and beta-ketone monitoring system and Boston Scientific’s Rhythmia EP-mapping system earned 510(k) clearances. Also, Boston Sci’s OptiCross imaging catheter gained regulatory clearance in three countries. More new product news.

Advertisement

Related Content

Bard EP Deal Latest In Boston Scientific’s M&A Revival, Bolsters CRM Business
Bard EP Deal Latest In Boston Scientific’s M&A Revival, Bolsters CRM Business
New Products In Brief
Emerging Peripheral Nerve Technologies Draw New Competitors To Neuromodulation Market

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

MT032282

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel